We performed a retrospective review of clinical T1a renal cell carcinoma patients treated in our institution. The clinicopathological findings and patients' prognoses were analyzed according to tumor size, and risk factors for tumor recurrence were elucidated.
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 920-8640 Takaramachi 13-1, Kanazawa, Ishikawa, Japan. yasukita@med.kanazawa-u.ac.jp